HALT-mRNA-RNASeq-mapped-reads - samples
Ontology highlight
ABSTRACT:
PROVIDER: EGAD00001003816 | EGA |
REPOSITORIES: EGA
Similar Datasets
Project description:Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer - Early Results from the COMPASS Trial - WGS mapped reads
| EGAD00001003585 | EGA
Project description:Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases - WGS mapped reads
| EGAD00001004551 | EGA
Project description:ICGC-TCGA DREAM Somatic Mutation Calling - Tumour Heterogeneity Challenge - WGS mapped reads
| EGAD00001003971 | EGA
Project description:Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer - Early Results from the COMPASS Trial - RNA-Seq mapped reads
| EGAD00001003584 | EGA
Project description:Ultra-Fast Patient-Derived Xenografts Identify Functional and Spatial Tumour Heterogeneities that Drive Therapeutic Resistance - WXS mapped reads
| EGAD00001003589 | EGA
Project description:Whole Genomes Define Concordance in Matched Primary, Xenograft, and Organoid Models of Pancreas Cancer - WGS mapped reads
| EGAD00001003586 | EGA
Project description:RNAseq of ZC3H5 interacting mRNA
| PRJEB38514 | ENA
Project description:UnlabelledWe describe a tool for quantifying the uniformity of mapped reads in high-throughput sequencing experiments. Our statistic directly measures the uniformity of both read position and fragment length, and we explain how to compute a P-value that can be used to quantify biases arising from experimental protocols and mapping procedures. Our method is useful for comparing different protocols in experiments such as RNA-Seq.Availability and implementationWe provide a freely available and open source python script that can be used to analyze raw read data or reads mapped to transcripts in BAM format at http://www.math.miami.edu/~vhower/ReadSpy.html.
| S-EPMC3467739 | biostudies-literature
Project description:We collected up to 6 separate analytes per patient from 14 HNSCC individuals and evaluated spatial (9 cases) and/or temporal (8 cases) variability using RNAseq. Sections taken from a frozen section using a crytostat were analysed for RNA quality was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies UK Ltd., Stockport, UK). Total RNA was converted into a library for sequencing on the HiSeq 2000 (Illumina Inc., San Diego, USA) using the TruSeq⢠stranded mRNA Sample Preparation Kit (Illumina Inc.). Briefly, poly-A mRNA was purified from total RNA (100ng) using the Poly(A) Purist Mag Kit (Life Technologies Ltd., Paisley, UK), according to the manufacturerâs instructions. The mRNA was then amplified and converted into cDNA, which was purified and used to construct libraries that were hybridized to the flow cell for single end (SE 35bp) sequencing. The protocol employed yielded 35-bp long reads. The quality of raw SE read data in FASTQ files were assessed and reads of low quality were trimmed or removed. SE reads were then mapped to the human genome (hg19) using TopHat (version 2.0.9) and, following the removal of multi-mapping reads, converted to gene specific read counts for annotated genes using HTSeq-count (version 0.5.4).
2017-09-15 | E-MTAB-4546 | biostudies-arrayexpress
Project description:Trypanosoma brucei Lister 427 bloodstream forms were cultured in HMI-11 medium. Total RNA was prepared using Qiagen RNAeasy kits for single sample RNAseq to estimate VSG mRNA abundance (and not to reconstruct the transcriptome). The cDNA libraries were prepared and sequenced at the Beijing Genomics Institute (Shenzhen, China). Polyadenylated RNA was purified from total RNA, converted to cDNA using random hexamer primers sheared and size selected for fragments ~200 bp in length using the Illumina TruSeq RNA Sample Preparation Kit v2. RNAseq of the resulting libraries was used for the determination of transcript abundances. Sequencing was performed on an Illumina Hiseq 2000 (Illumina, CA) platform and 90 base paired end reads obtained. Four samples were analysed: 1. Trypanosoma brucei Lister 427 expressing VSG2 2. Trypanosoma brucei Lister 427 expressing VSG6 3. Trypanosoma brucei Lister 427 expressing VSG6 and a VSG2 transgender located in the active bloodstream expression site 28 days after electroporation 4. Trypanosoma brucei Lister 427 expressing VSG6 and a VSG2 transgender located in the active bloodstream expression site 44 days after electroporation.
2020-06-03 | E-MTAB-9122 | biostudies-arrayexpress